Jaundice is one of the common conditions in full term and premature babies and appears usually in the first week of birth. Jaundice is caused due to the increased levels of bilirubin in the blood, where processing of the compound is slow as the infant’s liver is immature in the first week of birth. Jaundice in infants can be classified into physiological jaundice, breast-feeding jaundice, breast milk jaundice, and jaundice caused as a result of blood group incompatibility with the mother. Physiological jaundice is the most common form of jaundice in infants and is observed in more than 50% of the newborns. Phototherapy is a common mode of treatment in infants affected with jaundice. The treatment involves a process of using light waves which are absorbed by the skin and blood, resulting in the breakdown of bilirubin. The breakdown products of bilirubin after phototherapy do not cause any effects on the central nervous system. They are rapidly eliminated through the liver and kidneys.
The global infant phototherapy lamp market is anticipated to grow during the forecast period owing to the common presence of jaundice in neonates. In addition, low cost and ease of the treatment contribute to the growth of the market. However, alternate modes of treatment such as biliblanket, IVIG treatment, and exchange transfusion are projected to hinder the growth of the market. Furthermore, the phototherapy lamp treatment is anticipated to be associated with long-term effects such as testicular effects, transient DNA damage, and melanoma. This factor might drag the market growth. In addition, lack of research that accurately proves the negative effects of the phototherapy treatment is estimated to negatively impact the infant phototherapy lamp market.
The global infant phototherapy lamp market can be segmented based on product type, modality, end-user, and geography. On the basis of product type, the market can be segmented into conventional phototherapy devices and fiber optic phototherapy devices. Conventional phototherapy devices can be further sub-segmented into fluorescent lamps and light-emitting diode (LED) lamps. On the basis of modality, the market can be segmented into mobile phototherapy unit and fixed phototherapy unit. Based on the end-user, the market can be segmented into hospitals and neonate clinics.
A fiber optic phototherapy device comprises a pad of optic fibers that include a fiber optic bundle through which the light passes. This pad is placed close to the trunk of a neonate and hence does not require shielding of the eye. As a result, retinal injury and other eye complications can be prevented, making it the preferred choice of product for the treatment of jaundice in infants. Among the conventional phototherapy devices, fluorescent bulb is a commonly used device for the treatment. In terms of end-user, the neonate clinics segment of the market is anticipated to record a high growth during the forecast period.
On the basis of geography, the market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to be a high revenue generating region of the infant phototherapy lamp market in the near future. However, the Asia Pacific market is anticipated to expand at a high CAGR during the forecast period owing to increase in birth rate, focus on enhancing the health care facilities by governments, and growth in awareness among the population.
The leading global players operating in the infant phototherapy lamp market include Natus Medical Incorporated, GE Healthcare, Philips Lighting Holding B.V., Ibis Medical Equipment & Systems Pvt. Ltd., Dixion, Ardo, Drägerwerk AG & Co. KGaA, Beijing Julongsanyou Technology Co., Ltd., NOVOS Medical Systems, and Zhengzhou Dison Instrument And Meter Co., Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.